{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:05Z","timestamp":1792801565261,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T00:00:00Z","timestamp":1382400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100001288","name":"Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010173","name":"Smart Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.parkreldis.2013.08.017","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T06:01:39Z","timestamp":1378360899000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Randomized trial of IPX066, carbidopa\/levodopa extended release, in\u00a0early Parkinson's disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Rajesh","family":"Pahwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Fahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Pourcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherron","family":"Kell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21 Suppl.\u00a04","key":"10.1016\/j.parkreldis.2013.08.017_bib1","first-page":"S1","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2013.08.017_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002826-199402000-00004","article-title":"Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study","volume":"17","author":"Stocchi","year":"1994","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.parkreldis.2013.08.017_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.46.4.1059","article-title":"Early morning akinesia in Parkinson's disease: effect of standard carbidopa\/levodopa and sustained-release carbidopa\/levodopa","volume":"46","author":"Pahwa","year":"1996","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2013.08.017_bib4","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/mds.23861","article-title":"Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease","volume":"26","author":"Hauser","year":"2011","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2013.08.017_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"5","key":"10.1016\/j.parkreldis.2013.08.017_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2013.08.017_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.parkreldis.2013.08.017_bib8","series-title":"Recent developments in Parkinson's disease. II","first-page":"153","article-title":"Members of the UPDRS development committee. Unified Parkinson's disease rating scale","author":"Fahn","year":"1987"},{"issue":"3","key":"10.1016\/j.parkreldis.2013.08.017_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.parkreldis.2013.08.017_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archneur.56.5.529","article-title":"Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs later L-DOPA","volume":"56","author":"Fahn","year":"1999","journal-title":"Arch Neurol"},{"issue":"24","key":"10.1016\/j.parkreldis.2013.08.017_bib11","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Parkinson Study Group","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.parkreldis.2013.08.017_bib12","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/mds.22759","article-title":"Levodopa response in early Parkinson's disease","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2013.08.017_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mds.22343","article-title":"Double-blind trial of levodopa\/carbidopa\/entacapone versus levodopa\/carbidopa in early Parkinson's disease","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.parkreldis.2013.08.017_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mds.870130111","article-title":"Ropinirole in the treatment of early Parkinson\u2019s disease: a 6-month interim report of a 5-year levodopa-controlled study","volume":"13","author":"Rascol","year":"1998","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.parkreldis.2013.08.017_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.22060","article-title":"Initiating levodopa\/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study","volume":"68","author":"Stocchi","year":"2010","journal-title":"Ann Neurol"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:48Z","timestamp":1761178428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1353802013003118"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.08.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized trial of IPX066, carbidopa\/levodopa extended release, in\u00a0early Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}